These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10812222

  • 1. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF.
    Vaccine; 2000 Jun 15; 18(25):2804-7. PubMed ID: 10812222
    [Abstract] [Full Text] [Related]

  • 2. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY, Briggs DJ, Wu X, Davis RD, Moore SM, Gordon C, Xiang Z, Ertl HC, Tang DC, Fu ZF.
    Vet Microbiol; 2002 Apr 02; 85(4):295-303. PubMed ID: 11856579
    [Abstract] [Full Text] [Related]

  • 3. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S, Liu Y, Fooks AR, Zhang F, Hu R.
    Vaccine; 2008 Jan 17; 26(3):345-50. PubMed ID: 18083277
    [Abstract] [Full Text] [Related]

  • 4. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z.
    Antiviral Res; 2015 Sep 17; 121():9-15. PubMed ID: 26093157
    [Abstract] [Full Text] [Related]

  • 5. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N, Jackson FR, Niezgoda M, Ellison JA, Rupprecht CE, Nel LH.
    Vaccine; 2013 Aug 28; 31(38):4177-82. PubMed ID: 23867013
    [Abstract] [Full Text] [Related]

  • 6. A recombinant human adenovirus vaccine against rabies.
    Prevec L, Campbell JB, Christie BS, Belbeck L, Graham FL.
    J Infect Dis; 1990 Jan 28; 161(1):27-30. PubMed ID: 2295855
    [Abstract] [Full Text] [Related]

  • 7. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
    Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE.
    Virology; 2014 Feb 28; 450-451():243-9. PubMed ID: 24503087
    [Abstract] [Full Text] [Related]

  • 8. Canine adenovirus based rabies vaccines.
    Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M.
    Dev Biol (Basel); 2008 Feb 28; 131():467-76. PubMed ID: 18634509
    [Abstract] [Full Text] [Related]

  • 9. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
    Lodmell DL, Parnell MJ, Weyhrich JT, Ewalt LC.
    Vaccine; 2003 Sep 08; 21(25-26):3998-4002. PubMed ID: 12922136
    [Abstract] [Full Text] [Related]

  • 10. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ, Yang Y, Wilson JM, Ertl HC.
    Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532
    [Abstract] [Full Text] [Related]

  • 11. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H.
    Vaccine; 2002 Aug 19; 20(25-26):3155-64. PubMed ID: 12163267
    [Abstract] [Full Text] [Related]

  • 12. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein.
    Hu R, Zhang S, Fooks AR, Yuan H, Liu Y, Li H, Tu C, Xia X, Xiao Y.
    Microbes Infect; 2006 Apr 19; 8(4):1090-7. PubMed ID: 16524754
    [Abstract] [Full Text] [Related]

  • 13. Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines.
    Albas A, Pardo PE, Gomes AA, Bernardi F, Ito FH.
    Rev Soc Bras Med Trop; 1998 Apr 19; 31(4):367-71. PubMed ID: 9662964
    [Abstract] [Full Text] [Related]

  • 14. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
    Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z.
    J Virol; 2011 Aug 19; 85(16):8241-52. PubMed ID: 21632762
    [Abstract] [Full Text] [Related]

  • 15. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH, Zhang Y, Wang SH, Liu L, Yang F.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec 19; 25(6):650-4. PubMed ID: 14714304
    [Abstract] [Full Text] [Related]

  • 16. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM, Tutykhina IL, Logunov DIu, Verkhovskai LV, Nedosekov VV, Tsybanov SZh, Novikov BV, Narodnitskiĭ BS, Gintsburg AL.
    Zh Mikrobiol Epidemiol Immunobiol; 2006 Dec 19; (4):69-71. PubMed ID: 16941876
    [Abstract] [Full Text] [Related]

  • 17. [Rabies virus antibody titers in dogs in Campo Grande, Mato Grosso do Sul State, during the anti-rabies campaign, 2003].
    Rigo L, Honer MR.
    Rev Soc Bras Med Trop; 2006 Dec 19; 39(6):553-5. PubMed ID: 17308701
    [Abstract] [Full Text] [Related]

  • 18. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs.
    Yuan Z, Zhang S, Liu Y, Zhang F, Fooks AR, Li Q, Hu R.
    Vaccine; 2008 Mar 04; 26(10):1314-21. PubMed ID: 18262313
    [Abstract] [Full Text] [Related]

  • 19. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S, Sun C, Zhang S, Zhang X, Liu Y, Wang Y, Zhang F, Wu X, Hu R.
    Arch Virol; 2015 Sep 04; 160(9):2315-23. PubMed ID: 26143474
    [Abstract] [Full Text] [Related]

  • 20. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
    Liu X, Yang Y, Sun Z, Chen J, Ai J, Dun C, Fu ZF, Niu X, Guo X.
    PLoS One; 2014 Sep 04; 9(2):e87105. PubMed ID: 24498294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.